Latest News

Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Bridging the gap in Phase 1 clinical studies

April 2023

Here at Richmond Pharmacology, we focus mainly on Japanese cohorts in order to fast track global marketing authorisations in these important markets, ultimately reaching patients sooner.

View Articles

Futureproofing early phase clinical research for the next generation of investigators.

March 2023

Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.

View Articles

How Does Social Time Contribute to a Positive Workplace Culture?

March 2023

Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.

View Articles

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 2023

Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.

View Articles

Unlocking the potential of data sharing

January 2023

Dilshat Djumonov explores how GDPR is central to protecting private information while presenting unique challenges to the pharmaceutical clinical trials industry.

View Articles

How telemonitoring can revolutionise the way we treat patients – Tom York

November 2022

Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments.

View Articles

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Careers at Richmond

We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.

Our Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Von Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025

Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...

First patient enrolled in telehealth study, the Pathway Study

February 25, 2025

The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims...

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11

Exploring advancements shaping the future of healthcare.

View event

Low data variability

Exceptional ECG generation

Experts in cardiac safety

Our specialist services

News

Stay up to date with the latest activity at Richmond Pharmacology

Bridging the gap in Phase 1 clinical studies

Futureproofing early phase clinical research for the next generation of investigators.

How Does Social Time Contribute to a Positive Workplace Culture?

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

Unlocking the potential of data sharing

How telemonitoring can revolutionise the way we treat patients – Tom York

Meet the experts

Careers at Richmond

Our Videos

Latest news

Von Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

First patient enrolled in telehealth study, the Pathway Study

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

About us

Knowledge Base

Connect with us